We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

King, Astellas Sue Teva Over Adenoscan Patent

Law360 (June 10, 2005, 12:00 AM EDT) -- King Pharmaceuticals and Astellas Pharmaceuticals have filed a lawsuit against Israeli generics maker Teva Pharmaceutical for infringing violating King's patent on pharmacologic stress agent Adenoscan.

Filed in the U.S. District Court for the District of Delaware, the lawsuit seeks a court order prohibiting the U.S. Food and Drug Administration’s approval of Teva subsidiary Sicor's abbreviated new drug application for a generic version of Adenoscan (adenosine injection) before the expiration of King's U.S. patent, Astellas said.

Adenoscan is used as an adjunct to thallium-201 myocardial perfusion scintigraphy...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.